Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
|
Schindler Holding AG
F:SHRQ
|
CH |
|
Lemonade Inc
F:LE0
|
US |
|
E
|
Enanta Pharmaceuticals Inc
F:9EP
|
US |
|
Vera Bradley Inc
F:ELI
|
US |
Intrinsic Value
Is FPLB undervalued or overvalued?
See the intrinsic value estimate for 
Fisher & Paykel Healthcare Corporation Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
FPLB looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with FPLB’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Fisher & Paykel Healthcare Does
Fisher & Paykel Healthcare makes medical devices that help patients breathe more comfortably. Its main products include hospital systems for breathing support, heated humidification equipment, and sleep apnea therapy devices for home use. The company also supplies masks, tubing, and other disposable parts that are used with these systems.
- Headquarters
- New Zealand NZ
- Employees
- 7 506
- IPO date
- Nov 13, 2001
Fisher & Paykel Healthcare has a narrow economic moat
Hospitals using F&P systems also buy associated disposable supplies, and changing systems can mean replacing equipment and retraining staff. Patents protect some product designs, though established rivals such as ResMed and Philips in sleep and breathing care, and Vapotherm in high-flow therapy, offer alternatives.
Read the full moat analysis
Earnings Waterfall
Fisher & Paykel Healthcare Corporation Ltd
The intrinsic value for Fisher & Paykel Healthcare Corporation Ltd (FPLB) under the Base Case is hidden EUR.
Compared with the current market price of 24.6 EUR, the stock appears hidden.